Jan 10, 2022 / 04:30PM GMT
Operator
Hello. Thank you for standing by for this conference call. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions) I would now like to turn the conference over to Christine Cassiano, Chief Communications Officer. Ms. Cassiano, you may begin.
Christine Cassiano - Allogene Therapeutics, Inc. - Chief Communications Officer
Thank you, operator, and thanks to all of you for joining our call this morning. Before market open, Allogene issued a press release announcing that the FDA has removed the clinical hold on all of our AlloCAR T clinical trials. This press release as well as today's webcast are available on our website. Here with us to discuss today's news will be Dr. David Chang, our President and Chief Executive Officer; and Dr. Rafael Amado, Executive Vice President of Research and Development; and Chief Medical Officer.
During the Q&A, they will be joined by Dr. Eric Schmidt, Chief Financial Officer. (Operator Instructions) During today's call, we will be making certain forward-looking
Allogene Therapeutics Inc Business Update Call Transcript
Jan 10, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers